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Herpes Simplex Virus Type 1 gK Is Required for gB-Mediated
Virus-Induced Cell Fusion, While neither gB and
gK nor gB and UL20p Function Redundantly in
Virion De-Envelopment
Jeffrey M. Melancon, Rafael E. Luna, Timothy P. Foster, and Konstantin G. Kousoulas*
Division of Biotechnology and Molecular Medicine, School of Veterinary Medicine,
Louisiana State University, Baton Rouge, Louisiana

Multiple amino acid changes within herpes simplex virus type 1 (HSV-1) gB and gK cause extensive virusinduced cell fusion and the formation of multinucleated cells (syncytia). Early reports established that syncytial mutations in gK could not cause cell-to-cell fusion in the absence of gB. To investigate the interdependence of gB, gK, and UL20p in virus-induced cell fusion and virion de-envelopment from perinuclear spaces as
well as to compare the ultrastructural phenotypes of the different mutant viruses in a syngeneic HSV-1 (F) genetic
background, gB-null, gK-null, UL20-null, gB/gK double-null, and gB/UL20 double-null viruses were constructed
with the HSV-1 (F) bacterial artificial chromosome pYEBac102. The gK/gB double-null virus YEbac⌬gB⌬gK
was used to isolate the recombinant viruses gBsyn3⌬gK and gBamb1511⌬gK, which lack the gK gene and carry
the gBsyn3 or gBamb1511 syncytial mutation, respectively. Both viruses formed small nonsyncytial plaques on
noncomplementing Vero cells and large syncytial plaques on gK-complementing cells, indicating that gK
expression was necessary for gBsyn3- and gBamb1511-induced cell fusion. Lack of virus-induced cell fusion
was not due to defects in virion egress, since recombinant viruses specifying the gBsyn3 or gKsyn20 mutation
in the UL19/UL20 double-null genetic background caused extensive cell fusion on UL20-complementing cells.
As expected, the gB-null virus failed to produce infectious virus, but enveloped virion particles egressed
efficiently out of infected cells. The gK-null and UL20-null viruses exhibited cytoplasmic defects in virion
morphogenesis like those of the corresponding HSV-1 (KOS) mutant viruses. Similarly, the gB/gK double-null
and gB/UL20 double-null viruses accumulated capsids in the cytoplasm, indicating that gB, gK, and UL20p do
not function redundantly in membrane fusion during virion de-envelopment at the outer nuclear lamellae.
mic virion morphogenesis, since mutant viruses lacking either gK
or UL20p accumulate capsids within the cytoplasm that are unable to acquire envelopes by budding into trans-Golgi networkassociated membranes (3, 18, 19, 24, 31, 33, 41). Furthermore,
UL20p is essential for virus-induced cell fusion caused by either gB or gK syncytial mutations (19), and it is necessary for
gK cell surface expression (17, 19, 21), strongly suggesting that
direct or indirect interactions between gK and UL20 are necessary for intracellular protein trafficking, virus egress, and
virus-mediated cell-to-cell fusion (15, 17, 19, 24, 41).
Glycoprotein B (gB) is highly conserved across all subfamilies of herpesviruses. It exists within cells as a homodimeric
type I integral membrane protein that is N-glycosylated at
multiple sites (10, 11, 27, 37, 53, 59). A variety of evidence
indicates that gB plays important roles in membrane fusion
phenomena during virus entry and virus-induced cell fusion:
herpes simplex virus type 1 (HSV-1) mutants lacking gB are
not able to enter cells (6) due to a postattachment defect that
can be resolved by polyethylene glycol-mediated fusion of viral
envelopes with cellular membranes (7); single-amino-acid substitutions and truncations of the carboxyl terminus of gB cause
extensive virus-induced cell fusion (2, 5, 8, 25); and transient
coexpression of gB with gD, gH, and gL causes cell-to-cell
fusion, which is substantially increased by carboxyl-terminal
truncations of gB (20, 26, 34, 48). These results suggest a direct
role for gB in membrane fusion and suggest that perturbations

Herpes simplex viruses specify at least 11 virally encoded
glycoproteins as well as several nonglycosylated membraneassociated proteins that function in several important roles,
including virus entry via fusion of the viral envelope with cellular membranes, intracellular virion morphogenesis and egress,
cell-to-cell spread, and virus-induced cell fusion (42, 43, 53, 58,
60). Mutations that cause extensive virus-induced cell-to-cell fusion have been mapped to at least four regions of the viral genome: the UL20 gene (3, 40, 41), the UL24 gene (32, 57), the
UL27 gene encoding glycoprotein B (gB) (5, 47), and the UL53
gene coding for gK (4, 13, 29, 49, 50, 55).
The UL20 and UL53 (gK) genes encode multipass transmembrane proteins of 222 and 338 amino acids, respectively,
which are conserved in all alphaherpesviruses (13, 40, 51).
UL20p assumes a membrane topology that constitutes a mirror
image of gK with both the amino and carboxyl termini of UL20p
located intracellularly, while both the amino and carboxyl termini
of gK are located extracellularly (17, 21, 41). gK is known to be
posttranslationally modified by N-linked carbohydrate addition, while UL20p is not glycosylated (13, 29, 51). UL20p and
gK localize to trans-Golgi network membranes after endocytosis
from cell surfaces (21). UL20p and gK are essential for cytoplas* Corresponding author. Mailing address: Division of Biotechnology
and Molecular Medicine, School of Veterinary Medicine, Louisiana
State University, Baton Rouge, LA 70803. Phone: (225) 578-9682. Fax:
(225) 578-9655. E-mail: vtgusk@lsu.edu.
299

Downloaded from https://journals.asm.org/journal/jvi on 18 January 2022 by 2620:105:b001:1060:86f:667c:32f5:4ae9.

Received 10 June 2004/Accepted 25 August 2004

MELANCON ET AL.

of the carboxyl-terminal domains of gB facilitate gB-mediated
cell-to-cell fusion.
It has been shown that syncytial mutations in gK failed to
cause virus-induced cell fusion in the absence of gB, indicating
that gB was essential for gK-associated cell-to-cell fusion (7).
In this paper, we used the HSV-1 (F) bacterial artificial chromosome BAC system (62) to generate multiple mutant viruses
lacking either gK, UL20, or gB or combinations of gK and gB
or UL20 and gB. Comparison of the BAC-generated insertiondeletion mutants in the HSV-1 (F) genetic background revealed subtle but important differences in individual virus phenotypes in comparison to the laboratory-adapted virus strain
KOS, most likely due to the limited passage of these viruses in
cell culture. In addition, mutant viruses carrying syncytial mutations in gB in the absence of either gK or UL20 were generated. Characterization of these viruses revealed that gK is
necessary for gB-mediated virus-induced cell fusion. Concurrent deletion of either gB and gK or gB and UL20p did not
prevent perinuclear virion de-envelopment, indicating that gB
and gK or gB and UL20p do not function redundantly in
mediating fusion between the viral envelopes and the outer
nuclear membrane.
MATERIALS AND METHODS
Cells and viruses. African green monkey kidney (Vero) cells, CV-1 cells, and
293 cells were obtained from the American Type Culture Collection (Rockville,
Md.). Cells were maintained in Dulbecco’s modified Eagle’s medium (GibcoBRL; Grand Island, N.Y.), supplemented with 10% fetal calf serum and antibiotics. Fd20-1 cells and D6 cells were maintained as described previously (6, 41).
The UL19- and UL20-complementing cell line G5 was a gift of P. Desai (Johns
Hopkins Medical Center) (14). gKDIV5, gKsyn20DIV5, and tsB5 were described
previously (17, 23). Flp-In-CV-1 cells were maintained as directed by the manufacturer (Invitrogen, Carlsbad, Calif.).
Plasmids. Plasmid pcDNA5/FRT/gK was constructed by inserting the gK
gene, PCR amplified from KOS viral DNA, into pcDNA5/FRT/V5-His-TOPO
(Invitrogen). Plasmid p20F2 contains a 7,185-bp HSV-1 (KOS) genomic fragment spanning the region comprising UL19, UL20, UL21, and UL22 and was
described previously (41). Primers 5⬘CMVEGFP_20.5_BclI (5⬘-TTCTTCTTCT
TCTGATCATGCTGACGTAAGTAGTTATTAATAGTAATCAATTACGG
GG-3⬘) and 3⬘CMVEGFP_BclI (5⬘-CTCTTCCTCTCCTGATCAATGAGTTT
GGACAAACCACAACTAGA-3⬘) were used to PCR amplify a cytomegalovirus-enhanced green fluorescent protein (EGFP) gene cassette from pTF9200
(22). The resultant PCR product was digested with BclI and ligated into p20F2
that was restricted the BamHI and treated with calf intestinal phosphatase. The
resultant plasmid, designated p⌬1920-EGFP, contained a cytomegalovirus-EGFP
gene cassette which replaced the HSV-1 region in p20F2 contained within the
BamHI sites at genomic positions 39234 and 41549 (GenBank accession number
NC_001806), removing the entire UL20 open reading frame (ORF) as well as the
first 1,293 bp of the UL19 ORF.
Construction of transformed Flp-In-CV-1 cell lines. Generation of stable
Flp-In-CV-1 expression cell lines was performed essentially as directed by the
manufacturer (Invitrogen) and as described previously (41). Confluent Flp-InCV-1 monolayers in six-well plates were transfected with 0.3 g of pcDNA5/
FRT/gK and 2.7 g of pOG44 (Invitrogen), which expresses Flp recombinase,
with Lipofectamine 2000. After 2 weeks, hygromycin B (125 g/ml)-resistant
colonies were tested for the ability to complement the growth of YEbac⌬gK
virus. All colonies tested complemented YEbac⌬gK virus. Isolate FcgK-1, derived from pcDNA5/FRT/gK-transfected cells, was chosen for further use.
FcgK-1 cells were used in generating YEbac⌬gK virus stocks.
Construction of a replication-deficient adenovirus expressing gB. pAd5-Blue
is a replication-defective, E1- and E3-deleted adenovirus type 5 (Ad5)-containing plasmid (44). gB was PCR amplified from HSV-1 KOS viral DNA with
primers gB5⬘ClaI (5⬘-TCCTCCATCGATATGCGCCAGGGCGCCCCCG-3⬘)
and gB3⬘XbaI (5⬘-CTTCTTTCTAGATCACAGGTCGTCCTCGTCGGC-3⬘)
and transferred into the unique ClaI and XbaI sites located in the E1-deleted
region of pAd5-Blue, immediately downstream of the cytomegalovirus promoter,
to generate pAd5-gB. pAd5-gB was transfected into 293 cells in a T-25 flask with
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Lipofectamine 2000, according to the manufacturer’s directions (Invitrogen);
72 h posttransfection, cell lysates were prepared by multiple freeze-thaw cycles.
A small portion of the cell lysate was then used to infect a subsequent flask of 293
cells. After four passages, a high-titer stock of Ad5-gB was obtained, which was
deficient for replication on Vero cells. Ad5-gB virus at different multiplicities of
infection (MOIs) was tested for its ability to complement YEbac⌬gB on Vero
cells, and an MOI of 10 was found to be optimal.
Construction of HSV-1 mutants with deletions of the UL20, gB, and/or gK
genes (pYEbac102, pYEbac⌬gB, pYEbac⌬UL20, pYEbac⌬gK, pYEbac⌬gB⌬UL20,
and pYEbac⌬gB⌬gK). Insertion-deletion mutagenesis of pYEbac102 DNA was
accomplished in Escherichia coli with the  gam recE recT (GET) recombination
system (45, 46), as described previously for mutagenesis of the KSHV genome
(39). Electrocompetent YEbac102 Escherichia coli DH10B cells were transformed
with plasmid pGETrec, which contains the genes encoding recE, recT, and bacteriophage  gam, grown on plates containing chloramphenicol (12.5 g/ml) and ampicillin (100 g/ml). Individual colonies were picked and grown overnight in LuriaBertani (LB) medium containing chloramphenicol and ampicillin. The next day,
the culture was inoculated into 250 ml of LB containing chloramphenicol and
ampicillin until an optical density at 600 nm of 0.4 was reached. Addition of
L-arabinose to a final concentration of 0.2% (wt/vol) and further incubation for
40 min induced expression of the recE, recT and  gam genes from plasmid
pGETrec. The cells were then harvested and made electrocompetent.
For the ⌬UL20-GFPzeo mutation, a PCR fragment containing a GFP-zeocin
resistance (GFP-zeo) gene cassette flanked by ⬇50 bp of viral sequences on both
sides was used for recombination to construct pYEbac⌬UL20, containing the
GFP-zeo gene cassette within the targeted UL20 genomic region. For the ⌬gBKan mutation, a PCR fragment containing a kanamycin resistance gene cassette
flanked by ⬇50 bp of viral sequences on both sides was used for recombination
to construct pYEbac⌬gB, which contained the kanamycin resistance gene cassette within the targeted UL27 genomic region. For ⌬gK-GFPzeo, a PCR fragment containing a GFP-zeo gene cassette flanked by ⬇50 bp of viral sequences
on both sides was used for recombination to construct pYEbac⌬gK, containing
the GFP-zeo gene cassette within the targeted UL53 genomic region. Briefly, 40
l of electrocompetent DH10B cells harboring both pYEbac102 and pGETrec
were electroporated with 200 ng of each PCR product to delete the target gene
(gB, UL20, or gK) with standard electroporation parameters (1.8 kV/cm, 200 ⍀,
and 25 F). Following electroporation, cells were grown in 1 ml of LB for 60 min
and subsequently streaked onto LB agar plates containing chloramphenicol (12.5
g/ml) as well as either kanamycin (50 g/ml) or zeocin (25 g/ml). Mutant
pYEbac102 DNA containing a deletion in the gB, UL20, or gK gene was isolated
from bacterial colonies, and a second round of electroporation was performed to
remove plasmid pGETrec. Following electroporation, cells were grown on agar
plates containing chloramphenicol as well as either kanamycin or zeocin. Similar
procedures were followed, starting with electrocompetent DH10B E. coli cells harboring pYEbac⌬gB, in order to generate pYEbac⌬gB⌬gK and pYEbac⌬gB⌬UL20.
Confirmation of the targeted mutations in pYEbac102 DNA. HSV-1 BAC
DNAs (pYEbac102, pYEbac⌬gB, pYEbac⌬UL20, pYEbac⌬gK, pYEbac
⌬gB⌬UL20, and pYEbac⌬gB⌬gK) were purified from 500 ml of BAC cultures
with the Qiagen large-construct kit (Qiagen; Valencia, Calif.). BAC DNA was
digested with KpnI, run on a 0.7% agarose gel, and transferred to charged nylon
membranes (Bio-Rad; Richmond, Calif.). Southern blot hybridization was performed with either a 1.1-kb kanamycin or 800-bp GFP-zeocin PCR product
labeled with biotin (New England Biolabs; Boston, Mass.). Chemiluminescence
detection of the DNA was performed with the North2South chemiluminescent
hybridization and detection kit as described by the manufacturer (Pierce Inc.;
Rockford, Ill.). All mutations were sequenced to verify the presence of the
desired mutations in the BACs. To verify that no spurious mutations were
introduced into the viral genome of the individual BAC mutants during mutagenesis or during the transfection procedure, each null mutation was rescued
by homologous recombination with DNA fragments spanning each gene. Each
rescue virus was verified to have the phenotypic and replication characteristics of
the wild-type BAC YEbac102.
Transfection of HSV-1 BAC DNAs. Transient transfection of cells with BAC
DNAs was performed with Lipofectamine 2000 (Invitrogen). Complementing
cell lines were grown to 95% confluency in six-well plates. Cells were transfected
with BAC DNA mixed with Lipofectamine 2000 in Opti-MEM medium as recommended by the manufacturer (Invitrogen). After 6 h of incubation at 37°C, the medium was removed from the transfected cells, cells were washed with phosphatebuffered saline, and subsequent fresh Dulbecco’s modified Eagle’s medium with
10% fetal calf serum was added. At 72 h posttransfection, virus stocks were
collected.
Plaque morphology of YEbac102 mutants. For plaque morphology, Vero,
Fd20-1, FcgK-1, and D6 cells were infected at MOIs of 0.01 and 0.001 with
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Primer
designation

3⬘ UL20-GFPZeo
5⬘ UL20-GFPZeo
3⬘ gB-Kan
5⬘ gB-Kan
5⬘ gK-GFPZeo
3⬘ gK-GFPZeo
UL20-Rev
UL20-For
gB-Rev
gB-For
gK-For
gK-Rev

Name

5⬘-CACGGACATCCCCCAAAACACGGGCGCCGACAACGGCAGACGATCCCTCTTGATGTTagacatgataagatacattgatgagtttgg-3⬘
5⬘-CTGACGTAAGCGACCCTTTGCGGTTTCGGTCTCCCCACCTCCACCGCACACCCCgtccgttacataacttacggtaaatgg-3⬘
5⬘-GTTGGGAACTTGGGTGTAGTTGGTGTTGCGGCGCTTGCGCATGACCATGTCcggttgatgagagctttgttgtaggtggac-3⬘
5⬘-CTGACCCTGTGGAACGAGGCCCGCAAGCTGAACCCCAACGCCATCGCCTCGTGAccacgttgtgtctcaaaatctctgatgtta-3⬘
5⬘-AGCACCTCTCAACCGTCGTCTTGATAACGGCGTACGGCCTCGTGCTCGTGTGGTGAgtccgttacataacttacggtaaatgg-3⬘
5⬘-CAGTTTCCAATTTGCATATGCCGTTACGGTTTCCGCCGGCCTGGATGTGACGagacatgataagatacattgatgagtttgg-3⬘
5⬘-GAAGGCTGCGGCCTCGTTCCAG-3⬘
5⬘-ACGGCCTTATCAAAACACTCGCCTC-3⬘
5⬘-TCACAGGTCGTCCTCGTCGGC-3⬘
5⬘-GTGATCGACAAGATCAACGCCAAGG-3⬘
5⬘-GGCACGCCATGGTCGCCGTCCGTTCCCTGC-3⬘
5⬘-ATCACATACCCCGTTCCGCTTCCG-3⬘

Sequencea

TABLE 1. Synthetic oligonucleotide primers

A
B
C
D
E
F
a
b
c
d
e
f

Purpose and product
size (bp)

UL20 GET recombination (2,025)

gB GET recombination (1,209)

gK GET recombination (2,022)

Diagnostic PCR for wt UL20 (909)
or ⌬UL20-GFPZeo (2,469)
Diagnostic PCR for wt gB (2,127)
or ⌬gB-Kan (2,261)
Diagnostic PCR for wt gK (1,265)
or ⌬gK-GFPZeo (2,238)

Construction of HSV-1 BACs pYEbac⌬gB, pYEbac⌬UL20,
pYEbac⌬gK, pYEbac⌬gB⌬UL20, and pYEbac⌬gB⌬gK. The
complete HSV-1 (F) genome was recently cloned into a bacterial artificial chromosome (pYEbac102), enabling genetic
manipulation of the HSV-1 genome in E. coli (62). The BACbased GET homologous recombination system was used to
construct deletions within the gB, UL20, and gK genes in
E. coli. Deletion of each gene was accomplished by targeting
the gB, UL20, or gK open reading frame (ORF) with specific
primers as detailed in the Materials and Methods section. For
construction of the ⌬UL20-GFPzeo mutation, primers A and
B were used for homologous recombination and positioned to
remove a 353-bp region of the UL20 gene upon insertion of a
GFP-zeocin resistance gene cassette (Table 1; Fig. 1B and C),
extending from the UL20 ATG to an HpaI site inside the
UL20 ORF.

For GET recombination primers, the region homologous to HSV-1 DNA is in uppercase and the region which binds to the marker gene is in lowercase letters.

RESULTS

a

the YEbac102, YEbac⌬gB, YEbac⌬UL20, YEbac⌬gK, YEbac⌬gB⌬gK, and
YEbac⌬gB⌬UL20 viruses and visualized by immunohistochemistry at 48 h
postinfection with horseradish peroxidase-conjugated anti-HSV antibodies
(Dako) and Novared (VectorLabs) substrate development. For complementation of YEbac⌬gB⌬gK and YEbac⌬gB⌬UL20 viruses, Fd20-1 and FcgK-1 were
infected with Ad5-gB at an MOI of 10, 1 h prior to HSV-1 infection. Due to the
constitutive expression of gB in all cells, plaques were visualized by immunohistochemistry at 48 h postinfection with an anti-gD monoclonal antibody (RG1103; Rumbaugh-Goodwin Institute; Plantation, Fla.) with the Vectastain Elite
ABC kit and Novared substrate development kit (VectorLabs; Burlingame, Calif.)
according to the manufacturer’s directions and as described previously (17, 19).
One-step growth kinetics of YEbac102 mutants. Analysis of one-step growth
kinetics was as described previously (17, 23). Briefly, each virus at an MOI of 5
was adsorbed to approximately 6 ⫻ 105 Vero cells at 4°C for 1 h. Thereafter,
warm medium was added, and virus was allowed to penetrate for 2 h at 37°C. Any
remaining extracellular virus was inactivated by low-pH treatment (0.1 M glycine,
pH 3.0). Cells and supernatants were harvested immediately thereafter (0 h) or
after 4, 9, 16, 20, or 24 h of incubation at 37°C. Virus titers were determined by
endpoint titration of virus stocks on a complementing cell line.
Generation of recombinant UL20-null and gK-null viruses specifying mutant
gB. In order to generate recombinant viruses specifying mutations in gB, PCR
amplification of the UL27 region from purified viral DNA of YEbac102 (wildtype gB), tsb5 (gBsyn3), or amb1511 (gBamb1511) was performed. Each PCR
product was used for homologous recombination with both the YEbac⌬gB⌬UL20
and YEbac⌬gB⌬gK viruses. Virus plaques that formed on Fd20-1 (UL20 complementing) or FcgK-1 (gK complementing) cells were picked and sequentially
plaque purified at least five times. Replacement of the gB-null resident kanamycin resistance cassette and concomitant insertion of the specific mutant gB
gene were confirmed by DNA sequencing.
Generation of UL19 and UL20 double-null viruses. Viruses that contained a
cytomegalovirus immediate-early promoter-driven EGFP gene cassette in place
of a UL19/UL20 gene deletion were generated by homologous recombination
with plasmid p⌬1920-EGFP and the parental virus gKDIV5, gKsyn20DIV5, or
tsB5 (gBsyn3). G5 cells were transfected with p⌬1920-EGFP and at 6 h posttransfection were infected at an MOI of 0.1 with either gKDIV5, gKsyn20DIV5,
or tsB5 (gBsyn3) to generate UL19 and UL20 double-null viruses that were
designated ⌬1920, ⌬1920-syn20, and ⌬1920-syn3, respectively. Viruses were subsequently plaque isolated on G5 cells by fluorescence microscopy and sequentially plaque purified at least five times. Insertion of the cytomegalovirus-EGFP
gene cassette and the concomitant deletion of the UL19 and UL20 genes were
confirmed by diagnostic PCR and DNA sequencing.
Electron microscopy. Cell monolayers were infected with the indicated virus at
an MOI of 3. All cells were prepared for transmission electron microscopy
(TEM) examination 24 h postinfection. Infected cells were fixed in a mixture of
2% paraformaldehyde and 1.5% glutaraldehyde in 0.1 M sodium cacodylate
buffer, pH 7.3. Following treatment with 1% OsO4 and dehydration in an ethanol
series, the samples were embedded in Epon-Araldyte resin and polymerized at
70°C. Thin sections were made on an MTXL ultratome (RMC Products), stained
with 5% uranyl acetate and citrate/nitrate/acetate lead, and observed with a Zeiss
10 transmission electron microscope as described previously (19, 41).
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Inactivation of the gB gene was achieved by insertion of a
kanamycin resistance gene cassette within gB (⌬gB-Kan mutation). Specifically, primers C and D were designed to remove
a 970-bp fragment starting with gB ORF nucleotide 1655 upon
homologous recombination with pYEbac102 (Table 1; Fig. 1B
and C). This gB deletion does not disrupt the UL27.5 ORF
overlapping the 5⬘ end of gB (9) and is similar to that of the
K⌬T gB-null virus (6), with the exception that the ⌬gB-Kan
mutation was constructed to include a stop codon at the 5⬘ end
of the kanamycin resistance cassette ensuring that no aberrant
proteins could be made via a translational readthrough of the
kanamycin resistance gene cassette.
For construction of the ⌬gK-GFPzeo mutation, primers E
and F were positioned to delete almost the entire gK gene
(941 bp) without affecting the proximal UL52 gene, which
partially overlaps the gK ORF (Table 1; Fig. 1B and C). Each
pYEbac102 mutant construct contains one or more of the
insertion-deletion mutations mentioned above: pYEbac⌬gB
contains the ⌬gB-Kan mutation; pYEbac⌬UL20 contains
the ⌬UL20-GFPzeo mutation; pYEbac⌬gK contains the ⌬gKGFPzeo mutation; pYEbac⌬gB⌬UL20 contains both the ⌬gBKan and the ⌬UL20-GFPzeo mutations; and pYEbac⌬gB⌬gK
contains both the ⌬gB-Kan and the ⌬gK-GFPzeo mutations.
The YEbac102 viral constructs were tested for the presence
of the engineered insertion-deletion mutation via diagnostic
PCR. Primers a and b (Table 1; Fig. 1A), located outside of the
UL20 gene, amplified the predicted 909-bp diagnostic UL20
DNA fragments from BACs that contain wild-type UL20,
while a predicted 2,469-bp product was produced from BACs
that contain the ⌬UL20-GFPzeo mutation (Fig. 2A, panel i).
Primers c and d (Table 1; Fig. 1A) located within gB but
outside the deleted region amplified the predicted 2,127-bp
diagnostic gB DNA fragment from BACs that contain wildtype gB, while a predicted 2,261-bp product was produced
from BACs that contain the ⌬gB-Kan mutation (Fig. 2A, panel

iii). Primers e and f (Table 1; Fig. 1A) located outside of the gK
deletion region amplified a 1,265-bp diagnostic gK DNA fragment from BACs that contain wild-type UL20, while a predicted 2,238-bp product was produced from BACs that contain
the ⌬gK-GFPzeo mutation (Fig. 2A, panel ii).
Further confirmation of the genetic content of the pYEbac102
mutant constructs was obtained via restriction endonuclease
fragment analysis (Fig. 2B) and Southern blotting (Fig. 2C and
D). Restriction enzyme analysis of pYebac102, pYEbac⌬gB,
pYEbac⌬UL20, pYEbac⌬gK, pYEbac⌬gB⌬UL20 and pYEbac
⌬gB⌬gK DNA with KpnI produced a similar genomic DNA
restriction pattern with a few exceptions caused by the specified alterations of gB, UL20, and gK containing KpnI DNA
fragments. First, the 4,701-bp band containing the UL27 (gB)
ORF increased in size by 134 bp to 4,835 bp for pYEbac⌬gB,
pYEbac⌬gB⌬UL20, and pYEbac⌬gB⌬gK as a result of the
⌬gB-Kan mutation. This 4,835-bp KpnI DNA fragment (demarcated by a black arrow) was visible in the lanes labeled with
the above-mentioned constructs appearing between the predicted 4,680-bp and 4959-bp KpnI DNA fragments (Fig. 2B).
In addition, Southern blot analysis revealed that a kanamycin
resistance gene cassette probe hybridized to a single 4,835-bp
KpnI DNA fragment contained only in pYEbac⌬gB, pYEbac
⌬gB⌬UL20, and pYEbac⌬gB⌬gK restriction digests (indicated by a black arrow) (Fig. 2C), indicating that the ⌬gB-Kan
mutation had been successfully transferred into a single genomic site.
Second, the wild-type 9,432-bp KpnI DNA fragment containing the UL20 ORF increased in size by 1,560 bp to 10,992
bp for pYEbac⌬UL20 and pYEbac⌬gB⌬UL20. It is apparent
that the 9,432-bp band is missing in pYEbac⌬UL20 and
pYEbac⌬gB⌬UL20, as indicated by a gray arrow (Fig. 2B).
However, the 10,992-bp KpnI DNA fragment is not easily
identifiable due to the presence of KpnI genomic fragments
with predicted sizes of 10,837 and 11,024 bp. The 10,992-bp
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FIG. 1. Schematic of the strategy for the construction of pYEbac102 mutant BACs. (A) The top line represents the prototypic arrangement
of the HSV-1 genome, with the unique long (UL) and unique short (US) regions flanked by the terminal repeat (TR) and internal repeat (IR)
regions. (B) Shown below are the expanded genomic regions of the UL20, UL27, and UL53 ORFs as well as the approximate locations of the sites
to which insertion of the marker genes was targeted and the primers used in diagnostic PCR to confirm the presence of each mutation. (C) PCR
fragments containing the kanamycin resistance or GFP-zeocin resistance gene cassette flanked by ⬇50 bp of viral sequences on both sides were
used for targeted GET recombination in E. coli to construct pYEbac102 mutant BACs with insertion-deletion mutations in the UL20, UL27, and/or
UL53 ORFs. The approximate locations of the primers used in amplification of each PCR fragment are also shown.
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FIG. 2. Genomic analysis of pYEbac102 mutants. (A) Diagnostic PCR to confirm the insertion of the relevant gene cassettes in place of the
deleted genomic regions in UL20 (A, panel i) UL27 (gB) (A, panel ii), and UL53 (gK) (A, panel iii). (B) KpnI restriction fragment analysis of
pYEbac102 mutant BACs in comparison to wild-type pYEbac102. The black arrow demarcates the position of the KpnI DNA fragment altered
by the ⌬gB-Kan mutation, while the gray arrow points to the missing 9,432-bp fragment resulting from the ⌬UL20-GFPzeo mutation. (C and D)
Southern blot analysis of pYEbac102 mutant BACs. The KpnI-restricted BACs from panel B were hybridized with either a kanamycin resistance
gene (C) or GFP-zeocin resistance gene (D) biotinylated probe. The biotinylated kanamycin resistance gene probe hybridized to an estimated
4,835-bp DNA fragment in pYEbac⌬gB, pYEbac⌬gB⌬gUL20, and pYEbac⌬gB⌬gK DNA, which was absent in the wild-type pYEbac102 DNA
(indicated by a black arrow in panel C). The biotinylated GFP-zeocin probe identified a predicted 10,992-bp DNA fragment (gray arrow) in
pYEbac⌬UL20 and pYEbac⌬gB⌬gUL20 DNA corresponding to the ⌬UL20-GFPzeo mutation, and a predicted 8,956-bp fragment (white arrow)
in pYEbac⌬gK and pYEbac⌬gB⌬gK DNA corresponding to the ⌬gK-GFPzeo mutation (D).
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DNA fragment contains the ⌬UL20-GFPzeo mutation, which
was confirmed by probing the corresponding blot with a GFPzeocin probe (Fig. 2D, gray arrow). The GFP-zeocin probe
hybridized to unique DNA fragments of the predicted sizes
for both pYEbac⌬UL20 and pYEbac⌬gB⌬UL20. Finally, the
⌬gK-GFPzeo mutation is predicted to increase the size of the
wild-type 7,983-bp DNA fragment containing the UL53 (gK)
ORF by 973 to 8,956 bp. These DNA fragments were not
readily discernible in the ethidium bromide-stained restriction
profile (Fig. 2A). However, the GFP-zeocin probe hybridized
to the 8,956-bp DNA fragment (white arrow) in pYEbac⌬gK
and pYEbac⌬gB⌬gK, confirming the creation of the ⌬gKGFPzeo mutation (Fig. 2C). Again, the presence of a single
DNA fragment detected by the GFP-zeocin probe indicates
the absence of any spurious insertions.
Generation of infectious virus from pYEbac102-based constructs. To generate virus stocks from the mutant pYEbac102
constructs, transient transfection of individual BAC DNAs into
specific cell lines transformed with either the gB, UL20, or
gK gene and capable of complementing the resultant viruses
was performed. Specifically, pYEbac102 was transfected into
Vero cells, pYEbac⌬gB into gB-complementing D6 cells (6),
pYEbac⌬UL20 into UL20-complementing Fd20-1 cells (42),
and pYEbac⌬gK into FcgK-1 cells. The FcgK-1 cell line constitutively expresses the gK gene under the cytomegalovirus
immediate-early promoter and was constructed to efficiently
complement the ⌬gK-GFPzeo mutation and minimize the
chance for generation of wild-type viruses via recombination
with the endogenous gK gene (see Materials and Methods).
For all transfection experiments, virus plaques became visible
72 h posttransfection, and virus stocks exhibiting maximum
cytopathic effects were collected at appropriate points.
For complementation of the double-null viruses produced by
transfection of pYEbac⌬gB⌬UL20 and pYEbac⌬gB⌬gK, the
replication-deficient adenovirus Ad5-gB was constructed, which
constitutively expresses gB under the cytomegalovirus immediate-early promoter (see Materials and Methods). A series of
experiments were performed to assess the optimum MOI of
this virus that could maximize complementation of gB-null
viruses. These experiments showed that Ad5-gB at an MOI of
10 efficiently complemented gB-deficient viruses (not shown).
To complement double-null viruses having the gB gene deletion, UL20- or gK-complementing cell lines were infected with
Ad5-gB 1 h prior to transfection with pYEbac⌬gB⌬UL20 or
pYEbac⌬gB⌬gK. The same strategy was used to amplify virus
stocks of the double-null viruses.
Plaque morphology and growth kinetics of HSV-1 YEbac102
mutants. HSV-1 viruses containing deletions in UL20, gB, and
gK have been described previously (3, 6, 19, 30, 33). These
viruses were produced by homologous recombination of plasmid constructs with viral DNA in cell culture experiments.
Typically, isolation of these viruses required multiple plaque
purifications to ensure that the mutant virus stocks did not contain contaminating wild-type virus. In contrast, the YEbac102
UL20, gB, and gK null viruses were constructed in E. coli with
the GET recombination system (45, 46). In this case, production of mutant viruses did not require any plaque purification,
since the progeny viruses did not contain any contaminating
wild-type genomes.
To assess the effect of the deletion of the various genes on
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cell-to-cell spread, the plaque morphologies of the YEbac102,
YEbac⌬gB, YEbac⌬UL20, and YEbac⌬gK viruses were examined in Vero, Fd20-1, D6, and FcgK-1 cells at 48 h postinfection (Fig. 3). The wild type YEbac102 produced large plaques
of a similar size on all infected cells (Fig. 3A). Infection of noncomplementing cells with either YEbac⌬UL20 or YEbac⌬gK
resulted in small plaques containing on average three to five
cells (Fig. 3B1, B3, B4, D1, D3, and D3, respectively), while
complementation of the UL20 and gK gene deletions resulted
in large plaques comparable in size to the YEbac102 plaques
(Fig. 3B2 and D4, respectively). Similarly, infection of noncomplementing cells with the YEbac⌬gB virus produced only
single infected cells (Fig. 3C1, C2, and C4), indicating that the
virus was unable to spread beyond the primary infected cell,
while infection of complementing D6 cells resulted in large
plaques (Fig. 3C3). The YEbac⌬gB⌬UL20 and YEbac⌬gB⌬gK
double-null viruses formed large plaques when plated onto
Ad5-gB-infected Fd20-1 or FcgK-1 cells, respectively (Fig. 4A5
and B6), single infected cells on Vero cells, or cells able to
complement for only gK or UL20 (Fig. 4A1, A2, A4, B1, B2,
and B4), or very small plaques in cells able to complement gB
(Fig. 4A3, A6, B3, and B5).
Rescue of the individual mutations from each BAC-derived
virus was performed by homologous recombination with wildtype DNA fragments spanning each gene. Double-null mutations were rescued sequentially with the gB-null mutation rescued first followed by rescue of either the gK-null or UL20-null
mutations. Importantly, all rescued viruses formed large plaques
similar to the wild-type YEbac102 virus when plated on noncomplementing Vero cells, indicating that there were no spurious mutations in the parental mutant BAC viruses affecting
virus replication and egress (Fig. 4C, D, E, F, G, and H).
To examine the effect of the various mutations on virus
replication, Vero cells were infected at an MOI of 5 with either
the wild-type or a mutant virus. Virus stocks were prepared
at 0, 4, 9, 16, 20, or 24 h postinfection and titrated in triplicate onto complementing cells (Fig. 5). The kinetics of both
YEbac⌬UL20 and YEbac⌬gK viral replication was substantially slower than that of the YEbac102 virus. Maximum titers
for the YEbac⌬UL20 and YEbac⌬gK mutants viruses were 105
PFU/ml in comparison to 108 PFU/ml for the YEbac102 virus
at 24 h postinfection (Fig. 5). In contrast, the YEbac⌬gB,
YEbac⌬gB⌬UL20, and YEbac⌬gB⌬gK viruses failed to produce infectious virus in Vero cells (Fig. 5).
Ultrastructural characterization of the YEbac⌬gB⌬UL20
and YEbac⌬gB⌬gK double-null mutant viruses. Previous reports indicated that gB was not essential for virion egress (6, 7),
while both gK and UL20p were found to be essential for
cytoplasmic virion morphogenesis and egress (19, 33). To ascertain whether gB functioned redundantly with either gK or
UL20p in virion de-envelopment from perinuclear spaces, the
ultrastructural phenotypes of each YEbac102-based mutant
virus carrying UL20, gB, or gK deletions relative to the wildtype YEbac102 virus were determined by transmission electron
microscopy at 24 h postinfection.
As expected, the YEbac102 and YEbac⌬gB viruses exhibited no apparent defects in virion egress, exemplified by the
presence of fully enveloped virions extracellularly (Fig. 6A and
B) as well as the presence of fully enveloped virions intracellularly (not shown). Unlike the wild-type virus, ultrastructural
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FIG. 3. Plaque phenotypes of gB-, gK-, and UL20-null viruses. The plaque phenotypes of YEbac102, YEbac⌬UL20, YEbac⌬gB, and
YEbac⌬gK were observed on Vero (A1, B1, C1, and D1), Fd20-1 (A2, B2, C2, and D2), D6 (A3, B3, C3, and D3), and FcgK-1 (A4, B4, C4, and
D4) cells. Confluent cell monolayers were infected with wild-type YEbac102 (A1, A2, A3, and A4), YEbac⌬UL20 (B1, B2, B3, and B4), YEbac⌬gB
(C1, C2, C3, and C4), or YEbac⌬gK (D1, D2, D3, and D4) at an MOI of 0.001, and viral plaques were visualized at 48 h postinfection by
immunohistochemistry.

visualization of YEbac⌬UL20- and YEbac⌬gK-infected Vero
cells revealed a cytoplasmic defect in virion egress, characterized by the presence of unenveloped capsids in the cytoplasm
as well as aberrantly enveloped virions (Fig. 6C and D). These
results are consistent with previous findings (19, 33). In general, ultrastructural examination of Vero cells infected with
the YEbac⌬gB⌬gK (Fig. 7A) and YEbac⌬gB⌬UL20 (Fig. 7B)
double-null viruses revealed virion morphogenetic defects similar to those of the gK- and UL20-null viruses, exhibiting large
numbers of unenveloped capsids in the cytoplasm. In addition,
the observed ultrastructural phenotypes revealed specific
defects in cytoplasmic envelopment: (i) multiple capsids ap-

peared proximal to membranes apparently unable to complete
the budding process into cytoplasmic vesicles (Fig. 7A4 and
B3) and (ii) cytoplasmic vesicular membranes appeared to
contain electron-dense material consistent with the accumulation of tegument proteins in the presence or absence of proximal capsids (Fig. 7A5 and B4).
Generation and characterization of recombinant gK-null
and UL20-null viruses containing the gBsyn3 or gBamb1511
mutation. It was previously determined that gB was required
for expression of the syn20 (gK) syncytial phenotype (7). To
determine whether gK was required for virus-induced cell fusion due to syncytial mutations in gB, YEbac102-based recom-
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FIG. 4. Plaque phenotypes of double-null viruses and rescued viruses. The plaque phenotypes of YEbac⌬gB⌬gUL20 and YEbac⌬gB⌬gK on
Vero (A1 and B1), Fd20-1 (A2 and B2), D6 (A3 and B3), and FcgK-1 (A4 and B4) cells or Ad5-gB infected Fd20-1 (A5 and B5) and FcgK-1 (A6
and B6) cells are shown. Confluent cell monolayers were infected with YEbac⌬gB⌬gUL20 (A1, A2, A3, A4, A5, and A6) or YEbac⌬gB⌬gK (B1,
B2, B3, B4, B5, and B6) at an MOI of 0.001. The plaque phenotypes of the rescued gB-, gK-, and UL20-null (D, E, and F) and double-null (G
and H) viruses in comparison to the wild-type YEbac102 (C) on Vero cells are shown. Viral plaques were visualized at 48 h postinfection by
immunohistochemistry.

binant viruses carrying either the gBsyn3 or the gBamb1511
syncytial mutation in the absence of the gK gene were constructed. These viruses were constructed by rescuing the
YEbac⌬gB⌬gK virus with either wild-type gB, gBsyn3, or
gBamb1511 (see Materials and Methods). The same strategy
was used to isolate recombinant viruses carrying the gBsyn3 or
gBamb1511 mutation in the absence of the UL20 gene by
rescuing the gB deletion in the YEbac⌬gB⌬UL20 virus.
To assess the effect of each gB mutation on virus-induced
cell fusion, Vero cells as well as either gK- or UL20-complementing cells were infected with each mutant virus at an MOI
of 0.001. Virus plaques were visualized at 48 h postinfection by
immunohistochemistry as described previously (19, 41). Viruses specifying the wild-type, syn3, or amb1511 gB in the
gK-null background formed small, nonsyncytial plaques on
Vero cells (Fig. 8A, C, and E). As expected, the virus containing the wild-type gB formed large, nonsyncytial plaques on
FcgK-1 cells (Fig. 8B), while gK-null viruses specifying either
the gBsyn3 or gBamb1511 mutation formed large, syncytial
plaques on FcgK-1 cells (Fig. 8D and F). Similarly, UL20-null
viruses specifying wild-type, syn3, or amb1511 gB formed
small, nonsyncytial plaques on Vero cells (Fig. 8G, I, and K).
The UL20-null virus containing wild-type gB formed large,
nonsyncytial plaques on Fd20-1 cells (Fig. 8H), and the UL20null viruses specifying either the gBsyn3 or gBamb1511 muta-

FIG. 5. Viral replication kinetics. Comparison of the viral replication characteristics of YEbac102 (F),YEbac⌬UL20 (■),YEbac⌬gK
(Œ),YEbac⌬gB (E),YEbac⌬gB⌬UL20 (䊐), and YEbac⌬gB⌬gK (‚)
on Vero cells. One-step kinetics of infectious virus production were
calculated after infection at an MOI of 5 followed by incubation at
37°C.

Downloaded from https://journals.asm.org/journal/jvi on 18 January 2022 by 2620:105:b001:1060:86f:667c:32f5:4ae9.

306

HSV-1 MEMBRANE FUSION AND VIRION DE-ENVELOPMENT

307

FIG. 6. Ultrastructural morphology of gB-, gK-, and UL20-null viruses. Electron micrographs of Vero cells infected with YEbac102 (A),
YEbac⌬gB (B), YEbac⌬UL20 (C), or YEbac⌬gK (D). Confluent cell monolayers were infected at an MOI of 5, incubated at 37°C for 24 h, and
prepared for transmission electron microscopy. Nuclear (n), cytoplasmic (c), and extracellular (e) spaces are marked.

tion formed large, syncytial plaques on Fd20-1 cells (Fig. 8J
and L).
Virion assembly and egress are not required for either gBor gK-mediated virus-induced cell-to-cell fusion. To investigate the potential requirement for virion egress in virus-induced cell fusion, recombinant viruses carrying a UL19 and
UL20 deletion in an otherwise wild-type, syn20, or tsB5 genetic
background were constructed. UL19 encodes the major capsid
protein (VP5), and capsid formation cannot occur in its absence (14). Briefly, a cytomegalovirus-EGFP gene cassette was
inserted into the viral genome, effectively deleting a sizeable
portion of the UL19 ORF and all of the UL20 ORF. Recombinant viruses were isolated via fluorescence microscopy and
plaque purified on G5 cells, which complement the UL19/
UL20-null defect (14), and characterized as described in Materials and Methods. CV-1 or Fd20-1 cells were infected with
⌬1920, ⌬1920-syn20, and ⌬1920-syn3 viruses at an MOI of

0.005. As expected, these infections did not cause virus-induced cell fusion in noncomplementing CV-1 cells (Fig. 9A, C,
and E). However, the ⌬1920-syn20 and ⌬1920-syn3 viruses
formed syncytial plaques containing a range of 3 to 100 nuclei
per syncytium in Fd20-1 cells, which complement only UL20
(Fig. 9D and F), while the ⌬1920 virus failed to cause virusinduced cell fusion (Fig. 9B).
DISCUSSION
HSV-1 BAC-generated recombinant viruses. Investigation of
the structure and function of individual viral proteins has been
greatly facilitated through the use of recombinant viruses specifying mutated proteins. Typically, recombinant viruses have
been produced by homologous recombination between a mutated DNA fragment and viral genomes. In most instances, the
resultant recombinant viruses have to be extensively purified
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FIG. 8. Plaque morphology of gK- and UL20-null viruses carrying syncytial mutations in gB. Plaque phenotypes of gK-null (A, B, C, D, E, and
F) and UL20-null (G, H, I, J, K, and L) recombinant viruses containing specific gB mutations on Vero (A, C, E, G, I, and K) and FcgK-1 (B, D,
and F), or Fd20-1 (H, J, and L) cells. Confluent cell monolayers were infected with the gK-null viruses containing wild-type gB (A and B), gBsyn3
(C and D), or gBamb1511 (E and F) or UL20-null viruses containing wild-type gB (G and H), gBsyn3 (I and J), or gBamb1511 (K and L) at an
MOI of 0.001, and viral plaques were visualized at 48 h postinfection by immunohistochemistry. Insets are shown at 2.4⫻ magnification to facilitate
visualization of the nonsyncytial phenotype of the small plaques.

due to the presence of a large amount of contaminating wildtype viruses. Recently, the HSV-1 (F) genome was cloned into
a bacterial artificial chromosome (BAC) by inserting the BAC
into the intergenic region between UL3 and UL4 without deletion of any viral genes (62), unlike previously constructed
HSV-1 BACs, which contained deletions of one or more viral
genes (28, 56, 61). Transfection of the resultant pYEbac102
plasmid into cells resulted in production of the YK304 infectious virus, which was indistinguishable from wild-type HSV-1
in vitro and in vivo, exhibiting wild-type virulence in mice after
intracerebral inoculation (62).

Taking advantage of the HSV-1 pYEbac102 system, we generated recombinant viruses lacking either the gK, gB, or UL20
gene as well as viruses having deletions in both gK and gB or
gB and UL20. As expected, the gB/gK and gB/UL20 doublenull viruses failed to produce infectious virus or spread beyond
the primary infected Vero cells. Generally, the gK-, gB-, and
UL20-null viruses exhibited defects in virus replication and
plaque morphologies similar to those of corresponding viruses
constructed in the KOS genetic background. However, it was
noted that the HSV-1 (F) gK- and UL20-null viruses exhibited
up to 10-fold greater defects in virus replication, while virus

FIG. 7. Ultrastructural morphology of gB/gK and gB/UL20 double-null viruses. Electron micrographs of Vero cells infected with YEbac⌬gB⌬gUL20
(A1, A2, A3, A4, and A5) or YEbac⌬gB⌬gK (B1, B2, B3, and B4). Confluent cell monolayers were infected at an MOI of 5, incubated at 37°C
for 24 h, and prepared for transmission electron microscopy. Panels A4 and B3 show partially enveloped capsids. Panels A5 and B4 show a
tegument-like accumulation on membranes that are folded irregularly. Nuclear (n), cytoplasmic (c), and extracellular (e) spaces are marked.
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FIG. 9. Plaque phenotypes of ⌬1920, ⌬1920-syn20, and ⌬1920-syn3
viruses on CV-1 (A, C, and E) and FcgK-1 (B, D, and F) cells.
Confluent cell monolayers were infected with the ⌬1920 (A and B),
⌬1920-syn20 (C and D), or ⌬1920-syn3 (E and F) at an MOI of 0.001,
and viral plaques were visualized at 48 h postinfection by immunohistochemistry.

plaques were typically smaller than those produced by the KOS
mutant viruses. These results may be attributed to genetic
differences between the F and KOS virus strains, although no
apparent differences were noted between the wild-type viruses
with regard to their replication kinetics and plaque morphology. Alternatively, it is possible that the requirement for extensive passage of mutant viruses in the KOS background during
plaque purification may have resulted in improved adaptation
of these viruses for growth in Vero cells. In this regard, generation of mutant viruses via the pYEbac102 system provides a
unique advantage in assessment of the structure and function
of individual viral proteins without the potential complications
arising from extensive cell culture passage of virus stocks.
gB, UL20p, and gK are not required for virion de-envelopment. HSV-1 is thought to acquire an initial envelope when
capsids formed in the nucleus of cells bud into the perinuclear
space. Subsequently, a putative fusion event between viral envelopes and the outer nuclear membranes results in capsid
release into the cytoplasm. Final envelopment is thought to
occur by budding into cytoplasmic vesicles derived from the
trans-Golgi network or endosomes that facilitate egress of en-
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veloped virions to extracellular spaces (Fig. 10). Currently, it is
not known whether viral glycoproteins involved in virus entry
or virus-induced cell fusion also functions in this de-envelopment step. The results obtained in this study clearly show that
gK, UL20, and gB are not essential for virion de-envelopment.
In the case of gB, previous studies suggested that lack of gB
did not adversely influence egress of virion particles to supernatants of infected cells, although these virions lacked gB and
were rendered noninfectious (6, 7). Similar results have been
reported for gH, gL, and gD, which are thought to be required
for virus-induced and virus-free (transient expression) membrane fusion (16, 38, 54). Ultrastructural examination of the
gB-null virus confirmed initial findings and clearly showed that
lack of gB did not adversely affect the production of enveloped
virions in extracellular spaces. Investigations with recombinant
viruses specifying single gene deletions in either gB, gK, or
UL20p did not exclude the possibility that gB and gK may
function in a redundant manner to facilitate virion de-envelopment. This possibility can be discounted on the basis that the
gB/gK double-null virus efficiently produced unenveloped capsids in the cytoplasm of infected cells. Similar results were
obtained for the gB/UL20 double-null virus. Furthermore, it is
improbable that UL20p or gK alone could mediate virion deenvelopment because these two proteins act in a cooperative
manner for intracellular transport and virus-induced cell fusion. Construction of a triple-null virus lacking gB, gK, and
UL20p could resolve this possibility. Alternatively, other viral
glycoproteins such as gH/gL may function redundantly with
gK, UL20p, or gB in the de-envelopment process.
Virions found in perinuclear spaces are known to contain
the UL34 and UL31 tegument proteins, which are absent from
extracellular enveloped virions (52). Thus, it is possible that the
de-envelopment process involves tegument-membrane protein
interactions different from those occurring during virus entry. In
this regard, virion de-envelopment from perinuclear spaces
seems to bear little similarity to either virus entry or virusinduced cell fusion, suggesting that this membrane fusion event
may be regulated by a fundamentally different mechanism.
Role of gK in gB-mediated cell-to-cell fusion. Previous reports showed that gK syncytial mutations could not cause virusinduced cell fusion in the absence of gB, indicating that gB
served functions essential for cell-to-cell fusion (7). Both the
gBsyn3 and gBamb1511 mutations cause extensive virus-induced cell fusion (2, 5). However, unlike the gBsyn3 singleamino-acid mutation, which does not enhance gB-mediated
fusion in the transient coexpression system, the gBamb1511
truncation causes greatly enhanced fusion in the transient expression system (20). These findings suggest that the gBamb1511
truncation may disengage gB from other viral or cellular functions responsible for downregulation of the fusogenic potential
of gB. However, recombinant viruses containing the gB syncytial mutation gBsyn3 or gBamb1511 but lacking the gK or the
UL20 gene failed to cause virus-induced cell fusion, indicating
that expression of both gK and UL20p is required for gBmediated membrane fusion.
In addition, deletion of the carboxyl-terminal 28 amino acids
of gB specified by the amb1511 mutation does not abolish the
requirement for expression of both gK and UL20p in gBmediated virus-induced cell fusion, suggesting that gB amino
acid sequences other than the carboxyl-terminal 28 amino ac-
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FIG. 10. Schematic of HSV-1 virion morphogenesis and egress. (I) Mature capsids budding through the inner nuclear membrane into the
perinuclear space. (II) De-envelopment of perinuclear virions at the outer nuclear membrane. (III) Re-envelopment of cytoplasmic capsids by
budding into cytoplasmic vesicles. (IV) Final egress to the extracellular space.

ids are required for gK or UL20p regulatory interactions with
gB. Recently, gK expression was reported to inhibit membrane
fusion caused by coexpression of gB, gD, gH, and gL (1). These
findings seem to contradict results obtained herein with the
recombinant viruses lacking gK. However, a similar result was
reported for gM, which inhibited membrane fusion in the transient coexpression system (34, 36) but was required for virusinduced cell fusion caused by syncytial mutations in gB (12).
These results suggest that gM and gK may regulate virusinduced cell fusion both positively and negatively depending on
the presence of different sets of viral proteins.
Virion egress is not required in virus-induced cell fusion.
Virus-induced cell fusion starts at approximately 5 h postinfection at 37°C, at which time infectious virions are produced
and egress out of infected cells. Therefore, it is possible that
egressing virions may contribute directly or indirectly to the
virus-induced membrane fusion phenomena mediated by cell
surface-expressed gB and gK carrying syncytial mutations. It
has been shown that cell surface expression of gB is not affected in a gK-null or UL20-null virus (19, 33). Therefore, the
requirement for the presence of UL20p and gK for gB-mediated virus-induced cell fusion may be due to defects in virion
egress. Earlier reports indicated that production of virion particles may not be necessary for virus-induced cell fusion, inasmuch as syncytial mutants caused fusion in the presence of the
replication inhibitor phosphonoacetic acid (35). These early findings were confirmed herein by the phenotype of the UL19/UL20
double-null viruses containing either the gBsyn3 or gBamb1511
mutation. These viruses are unable to form capsids because of

the deletion in the UL19 gene, coding for the major capsid protein VP5. Both viruses caused virus-induced cell fusion in the
UL20-complementing cell line, indicating that virion formation and egress are not necessary for virus-induced cell fusion.
The rapid generation of recombinant viruses with the
YEbac102 system greatly facilitates the characterization of the
function of individual viral proteins while helping to discern
potentially complex interactions among multiple proteins
through the introduction of multiple mutations into an identical genetic background. In this report, we have demonstrated
the utility of this system in investigating the role of gB, gK, and
UL20p in virus-induced cell fusion and morphogenesis. The
existence of an intimate relationship between gK/UL20p and
gB in virus-induced cell fusion suggests that both gK and
UL20p act to regulate the fusogenic properties of gB. Future
studies will investigate direct physical interactions among gB,
gK, and UL20p and their role in the regulation of membrane
fusion phenomena in the HSV-1 life cycle.
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